Ani Pharmaceuticals (ANIP) Interest & Investment Income (2010 - 2013)
Ani Pharmaceuticals (ANIP) posted Interest & Investment Income of $1860.0 for Q1 2013, down 42.57% sequentially from $3239.0 in Q4 2012, and down 6.63% YoY from $1992.0 in Q1 2012.
Ani Pharmaceuticals (ANIP) Interest & Investment Income (2010 - 2013) Analysis & Trends
Ani Pharmaceuticals has reported Interest & Investment Income for 4 years, with the latest figure at $1860.0 in Q1 2013.
- Quarterly Interest & Investment Income fell 6.63% year-over-year to $1860.0 in Q1 2013, while the trailing twelve-month figure through Mar 2013 was $8407.0 (up 18.86% YoY) and the FY2012 annual result came in at $8539.0, up 2.56% from the prior year.
- Interest & Investment Income slipped to $1860.0 in Q1 2013 per ANIP's latest filing, from $3239.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $7199.0 in Q4 2010 and troughed at $1431.0 in Q2 2012.
- A 4-year average of $2853.6 and a median of $1877.0 in 2012 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2011 and 2012: Interest & Investment Income plunged 74.25% in 2011, then jumped 74.7% in 2012.
- Over 4 years, Interest & Investment Income stood at $7199.0 in 2010, then slumped by 74.25% to $1854.0 in 2011, then surged by 74.7% to $3239.0 in 2012, then slumped by 42.57% to $1860.0 in 2013.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $1860.0, $3239.0, and $1877.0 for Q1 2013, Q4 2012, and Q3 2012 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | -3.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 1,860.00 |
| Dec 31, 2012 | 3,239.00 |
| Sep 30, 2012 | 1,877.00 |
| Jun 30, 2012 | 1,431.00 |
| Mar 31, 2012 | 1,992.00 |
| Dec 31, 2011 | 1,854.00 |
| Sep 30, 2011 | 1,516.00 |
| Jun 30, 2011 | 1,711.00 |
| Mar 31, 2011 | 3,245.00 |
| Dec 31, 2010 | 7,199.00 |
| Sep 30, 2010 | 5,466.00 |